03/20/2024 4:13 PM | BioMarin Pharmaceutical (Issuer) Slamon Dennis (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:48 PM | BioMarin Pharmaceutical (Issuer) Mueller Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:50 PM | BioMarin Pharmaceutical (Issuer) Guyer Charles Greg (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:53 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:55 PM | BioMarin Pharmaceutical (Issuer) Burkhart Erin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:36 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:40 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/19/2024 7:42 PM | BioMarin Pharmaceutical (Issuer) Hardy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:46 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:54 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:32 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:35 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 11:04 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 1:41 PM | BioMarin Pharmaceutical (Subject) FUCHS HENRY J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 11:04 AM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:10 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:12 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:14 PM | BioMarin Pharmaceutical (Issuer) Guyer Charles Greg (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:16 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:18 PM | BioMarin Pharmaceutical (Issuer) Mueller Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:05 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 9:35 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 12:34 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/13/2024 12:21 PM | BioMarin Pharmaceutical (Subject) DODGE & COX (Filed by)
| Form SC 13G/A | |
02/12/2024 4:20 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 2:24 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/09/2024 4:46 PM | BioMarin Pharmaceutical (Subject) Capital Research Global Investors (Filed by)
| Form SC 13G | |
02/09/2024 9:36 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 8:46 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 6:47 PM | BioMarin Pharmaceutical (Issuer) MEIER RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:06 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 1:40 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 9:09 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 10:48 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023 12:00 PM | BioMarin Pharmaceutical (Issuer) Countouriotis Athena (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/28/2023 12:03 PM | BioMarin Pharmaceutical (Issuer) Countouriotis Athena (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 12:11 PM | BioMarin Pharmaceutical (Issuer) Enyedy Mark J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/28/2023 12:13 PM | BioMarin Pharmaceutical (Issuer) Enyedy Mark J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 12:15 PM | BioMarin Pharmaceutical (Issuer) Bodem Barbara W. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/28/2023 12:18 PM | BioMarin Pharmaceutical (Issuer) Bodem Barbara W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:14 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Top Project Outperforms BTC in 2023… (Ad) According to a recently published report…
One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen.
And now, this crypto coin is set to soar in the parabolic bull run projected in 2024. Just click here for instant access to the #1 Coin for 2024. |
12/21/2023 8:57 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 4:22 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/14/2023 5:18 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 10:49 AM | BioMarin Pharmaceutical (Subject) Davis George Eric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 6:55 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:13 PM | BioMarin Pharmaceutical (Issuer) Hardy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 1:53 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023 2:57 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 9:27 AM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023 12:59 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 12:35 PM | BioMarin Pharmaceutical (Subject) FUCHS HENRY J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 6:05 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 6:08 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 12:30 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023 9:39 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 11:48 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023 3:05 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 10:35 AM | BioMarin Pharmaceutical (Issuer) Mueller Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:23 PM | Alles Mark J (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:24 PM | ANDERSON ELIZABETH M (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:24 PM | BioMarin Pharmaceutical (Issuer) Dere Willard H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:25 PM | BioMarin Pharmaceutical (Issuer) HERON ELAINE J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:26 PM | BioMarin Pharmaceutical (Issuer) Ho Maykin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:26 PM | BioMarin Pharmaceutical (Issuer) HOMBACH ROBERT J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:27 PM | BioMarin Pharmaceutical (Issuer) LAWLIS V BRYAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:27 PM | BioMarin Pharmaceutical (Issuer) MEIER RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:28 PM | BioMarin Pharmaceutical (Issuer) PYOTT DAVID E I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:29 PM | BioMarin Pharmaceutical (Issuer) Slamon Dennis (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 4:31 PM | BioMarin Pharmaceutical (Issuer) Burkhart Erin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 4:19 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 5:14 PM | BioMarin Pharmaceutical (Issuer) HERON ELAINE J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 5:14 PM | BioMarin Pharmaceutical (Issuer) MEIER RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 4:22 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 11:44 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023 8:48 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023 10:23 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2023 12:23 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/11/2023 3:48 PM | BioMarin Pharmaceutical (Filer)
| Form ARS | |
04/11/2023 3:30 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/11/2023 3:31 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
04/10/2023 6:00 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2023 10:11 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/06/2023 9:47 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2023 6:59 PM | BioMarin Pharmaceutical (Issuer) LAWLIS V BRYAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2023 1:18 PM | BioMarin Pharmaceutical (Subject) LAWLIS V BRYAN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |